|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea LJ, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Ferri B, Campillo JA, Martinez-Sanchez MV, Minguela A. Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies. Biomedicines. 2025 Jan 10;13(1):156. doi: 10.3390/biomedicines13010156. PubMed PMID: 39857739; PubMed Central PMCID: PMC11760850.
AÑO: 2025; IF: 3.9
|
39857739
|
Encarnación J.A., Coll E., Manso C., Llorente S., Morales F., Saura I., López-Cubillana P., Martínez-Valls P.L.G., Martínez G., De la Fuente I., Cárdenas E., Alonso-Romero J.L., Ruiz P., Moya J., Domínguez-Gil B., Royo-Villanova M. Outcomes of Kidney Transplantation from Deceased Donors with Severe Acute Kidney Injury (AKIN Stage 3): A Preliminary Single-Centre Analysis. Medical Sciences. September 2025. 13. 10.3390/medsci13030188
AÑO: 2025; IF: 4.4
|
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Jesus Asensio Egea L, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Ferri B, Campillo JA, Galindo F, Boix F, Martinez-Sanchez MV, Martinez-Hernandez MD, Minguela A. Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer. Front Cell Dev Biol. 2025 Sep 4;13:1632101. doi: 10.3389/fcell.2025.1632101. eCollection 2025. PubMed PMID: 40977889; PubMed Central PMCID: PMC12443833.
AÑO: 2025; IF: 4.3
|
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea LJ, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Escudero-Bregante JF, Ferri B, Campillo JA, Pons-Fuster E, Martinez Hernandez MD, Martinez-Sanchez MV, Ceballos D, Minguela A. Exploring the Immunoresponse in Bladder Cancer Immunotherapy. Cells. 2024 Nov 22;13(23):1937. doi: 10.3390/cells13231937. PubMed PMID: 39682686; PubMed Central PMCID: PMC11640729.
AÑO: 2024; IF: 5.2
|
|
Guillamon CF, Gimeno L, Server G, Martinez-Sanchez MV, Escudero JF, Lopez-Cubillana P, Cabezas-Herrera J, Campillo JA, Abellan DJ, Martinez-Garcia J, Martinez-Escribano J, Ferri B, Lopez-Alvarez MR, Moreno-Alarcon C, Moya-Quiles MR, Muro M, Minguela A. Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers. Eur Urol Oncol. 2021 Apr;4(2):246-255. doi: 10.1016/j.euo.2019.04.009. Epub 2019 May 14. PubMed PMID: 31411976.
AÑO: 2021; IF: 8.208
|